Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

MiMedx Group, Inc (MDXG) had Revenue of $98.61M for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$98.61M
Net Income	$9.62M
Cost of Goods Sold	$18.68M
Gross Profit	$79.92M
Operating Expenses	$86.23M
Operating Income	$12.37M
Non-Operating Income/Expense	$0.64M
Pre-Tax Income	$13.01M
Normalized Pre-Tax Income	$13.01M
Income after Taxes	$9.62M
Income from Continuous Operations	$9.62M
Consolidated Net Income/Loss	$9.62M
Normalized Income after Taxes	$9.62M
EBIT	$12.37M
EBITDA	$15.40M
Weighted-Average Shares Outstanding (Basic)	147.76M
Weighted-Average Shares Outstanding (Diluted)	149.32M
Earnings per Share (EPS) (Basic)	$0.07
Earnings per Share (EPS) (Diluted)	$0.06
Balance Sheet Financials
Current Assets	$220.88M
Property, Plant, and Equipment	$5.39M
Long-Term Assets	$70.23M
Total Assets	$291.11M
Current Liabilities	$50.29M
Long-Term Debt	$17.21M
Long-Term Liabilities	$24.20M
Total Liabilities	$74.48M
Common Equity	$216.62M
Tangible Shareholders Equity	$185.16M
Shareholders Equity	$216.62M
Common Shares Outstanding	147.93M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$19.72M
Cash Flow from Investing Activities	$-1.29M
Cash Flow from Financial Activities	$-3.97M
Beginning Cash	$104.42M
End Cash	$118.87M
Increase/Decrease in Cash	$14.45M
Stock-Based Compensation	$9.01M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.39
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.07
Debt to Equity Ratio	0.09
Gross Margin	81.05%
Operating Margin	12.54%
EBIT Margin	12.54%
EBITDA Margin	--
Pre-Tax Profit Margin	13.19%
Profit Margin	9.75%
Free Cash Flow	$19.12M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.34
Inventory Turnover	0.75
Receiveable Turnover	1.42
Days Sales in Receivables	63.19
Return on Equity	4.44%
Return on Tangible Equity	5.19%
Return on Assets	3.30%
Return on Investments	4.11%
Book Value Per Share	$1.46
Free Cash Flow per Share	$0.13
Operating Cash Flow per Share	$0.13

Data from Zacks Investment Research, Inc.